-
Published08/11/2024
-
Deadline09/12/2024
-
Opening of tenders09/12/2024
-
Awarded13/12/2024
-
Today16/03/2025
Utilities
- indicates text translated automatically in your browsing language
BvA_Patent_80.1 Text automatically translated in your browsing language Automatically translated
It is intended to conclude drug-selective rebate agreements with pharmaceutical companies within the meaning of § 130a(8) SGB V on the supply of finished medicinal products in accordance with the procurement documents available in electronic form. The award is divided into active substance-related compartment lots. For details, reference is made to the contract terms and the price sheets for the individual specialist lots as part of the procurement documents. Text automatically translated in your browsing language Automatically translated
https://www.dtvp.de/Satellite/notice/CXP4YRZ5YZ3
https://www.dtvp.de/Satellite/notice/CXP4YRZ5YZ3
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.